Next-Generation Diagnostics: T2 Biosystems

T2’s revolutionary new technology is based on clinically-proven magnetic resonance  MR technology, and uses nanoparticles coupled with reagents to quickly detect—within minutes—the presence of specific substances in solution using a miniaturized, portable MRI instrument. Detection of the high level magnetic resonance signal from the solution enables the detection of low concentrations of target agents or substances.

Unlike most existing diagnostic detection techniques which are based on optical detection methods that require pure samples and multiple processing steps, T2’s technology is not optical and therefore does not require purification of biological samples. This significant advantage allows the T2 system to perform single-step processing and rapid turnaround times without the need for trained technicians.

Furthermore, the technology can accurately identify almost any specimen, including proteins, nucleic acids, or enzymes; bacterial, cancer or other cells; viruses; or small molecule drug compounds within almost any sample, including whole blood, plasma, serum and urine.

T2’s system is faster, more reliable, more portable and more readily accessible than any diagnostic testing system now on the market.